- 041MarketSource · Medical Device Network
Merck KGaA to buy Bio-Techne for $11.3bn in life science footprint expansion
Merck KGaA announced an $11.3 billion acquisition of Bio-Techne, a life sciences company, marking its largest deal since the 2015 purchase of Sigma-Aldrich for $17 billion. The transaction expands Merck's portfolio in research reagents, instruments, and related life science tools supplied to labs and medical institutions.
- 042MarketSource · Medical Device Network
Advanced Medical Solutions mulls £715m HB Fuller takeover bid
Advanced Medical Solutions is considering a £715 million acquisition of HB Fuller, which the companies say would expand the combined addressable market by $15 billion and add approximately $300 million in annual revenue. The deal represents a significant consolidation move within the medical equipment and supplies sector.
- 043MarketSource · Medical Device Network
Tissium wins €60m to bring sutureless nerve repair system to market
Tissium secured €60 million in financing to commercialize COAPTIUM CONNECT, a sutureless peripheral nerve repair surgical system, in the US market. The device represents a new approach to nerve repair that avoids traditional suturing techniques.
- 044MarketSource · MedCity News
Cadence Rakes In $100M to Automate Chronic Care at Scale
Cadence, an AI-powered chronic care platform, raised $100 million in Series C funding at a $1.23 billion valuation. The company's software monitors patients at home and adjusts medications in real time for heart failure, hypertension, and diabetes management through partnerships with health systems.
- 045MarketSource · MedCity News
Startup Raises $7M for Virtual-First Pediatric Therapy Model
Ladder Health closed a $7 million seed round led by Nina Capital to develop a virtual-first pediatric therapy platform. The funding round included participation from nine additional investors including Mairs & Power Venture Capital, Hatteras Venture Partners, and Create Health Ventures. The company is positioning itself in the digital health space for pediatric rehabilitation and therapy services.
- 046MarketSource · Medical Design & Outsourcing
VitalPath expands catheter manufacturing facility
VitalPath expanded its catheter manufacturing facility in Maplewood, Minnesota into a collaboration hub consolidating executive leadership, new product development, new product introduction, sustaining engineering, and manufacturing operations under one roof. The company said the consolidated approach aims to improve coordination across product development and manufacturing teams.
- 047MarketSource · Medical Device Network
ZEISS and Envision Health strike VR partnership to advance glaucoma care
ZEISS and Envision Health have formed a partnership to develop virtual-reality applications for glaucoma care. The collaboration combines ZEISS's optical and imaging expertise with Envision Health's digital-health platform to create tools aimed at improving diagnosis, monitoring, and patient management in glaucoma treatment.
- 048MarketSource · Medical Device Network
Zeal Specialty to support Chemo Mouthpiece device access in US
Chemomouthpiece has partnered with Zeal Specialty Pharmacy to expand US distribution of its Chemo Mouthpiece, an oral cooling device designed to reduce chemotherapy-induced oral mucositis. The partnership leverages Zeal's specialty pharmacy network to improve patient access to the device.
- 049MarketSource · Medical Device Network
Sonire Therapeutics awarded $13m from Japanese government-backed innovation agency
Sonire Therapeutics received a $13 million award from a Japanese government-backed innovation agency. The funding supports the company's development efforts, signaling continued investment in the vendor's technology platform and market expansion in Japan.
- 050MarketSource · Medical Design & Outsourcing
Cretex Medical expands with Holland Molds deal
Cretex Medical, a subsidiary of Cretex Cos., acquired select assets and capabilities from Holland Molds Inc. in Wadena, Minnesota, with the deal closing June 10. The purchase expands Cretex Medical's contract manufacturing and engineering service offerings through its Brooklyn Park-based Component & Device Technologies division.
- 051MarketSource · Medical Device Network
Italy’s WISE raises $34.8m in Series D to advance spinal cord stimulator development
WISE, an Italian medical device company, raised $34.8 million in Series D funding to advance development of its spinal cord stimulator (SCS) system. The device delivers targeted, directional stimulation via minimally invasive percutaneous implantation. The funding will support continued product development and commercialization efforts.
- 052MarketSource · Medical Device Network
Memphasys and Monash IVF sign national supply deal for Felix system
Memphasys and Monash IVF Group have signed a 12-month exclusive national supply agreement for the Felix automated sperm selection system. The deal grants Monash IVF exclusive rights to distribute the device across Australia.
- 053MarketSource · Medical Device Network
J&J outlays $1bn to strengthen Floridian contact lens manufacturing provision
Johnson & Johnson is investing $1 billion to strengthen its contact lens manufacturing capacity in Florida, specifically for its ACUVUE product line. The capital expenditure aims to enhance supply chain resilience and production capabilities for the contact lens portfolio.
- 054MarketSource · Medical Design & Outsourcing
MGS expands hybrid tooling for faster healthcare development
MGS, a healthcare contract development and manufacturing organization, expanded its hybrid tooling capabilities globally. The offering enables pharmaceutical, diagnostics, and medical device companies to validate product designs under production-like conditions before committing to full-scale manufacturing tooling, aimed at accelerating development timelines and reducing time-to-market.
- 055MarketSource · Medical Device Network
How Shockwave Medical plans to keep rivals at bay in burgeoning IVL sector
Shockwave Medical is strengthening its competitive position in the intravascular lithotripsy (IVL) market as rivals explore entry into the sector. The company is pursuing a strategy centered on continued innovation and clinical data generation to defend its market share against emerging competition.
- 056MarketSource · Medical Device Network
Podcast: How Shockwave Medical plans to keep rivals at bay in burgeoning IVL sector
Shockwave Medical, the pioneer in intravascular lithotripsy (IVL), is discussing competitive strategy as the sector gains traction and new entrants approach. IVL uses acoustic pulse technology to treat calcified vascular lesions, and Shockwave's early-mover advantage has driven strong adoption. The podcast explores how the company plans to maintain market position amid emerging competition in this growing interventional cardiology segment.
- 057MarketSource · Medical Design & Outsourcing
Gerresheimer expands Georgia plant and makes automation upgrades
Gerresheimer, a German medical device CDMO, has expanded its Peachtree City, Georgia manufacturing facility and installed two automated storage and retrieval systems (AS/RS) to boost production and logistics capacity. The plant manufactures inhalers, infusion components, microinjectors, microbiological test cards, and autoinjectors.
- 058MarketSource · Medical Device Network
GT Medical Technologies raises $100m for brain tumour therapy advance
GT Medical Technologies secured $100 million in funding to advance its GammaTile brachytherapy system for brain tumor treatment. The company presented final Phase III clinical data comparing GammaTile against standard of care at the ASCO annual meeting, supporting the device's therapeutic profile and market positioning.
- 059MarketSource · Medical Design & Outsourcing
Covestro, Insulectro expand flexible electronics access
Covestro and Insulectro announced a partnership to expand access to advanced film materials and technical support for flexible electronics manufacturers across the Americas. The collaboration targets growing demand in stretchable circuits, wearable devices, medical technologies, and robotics applications.
- 060MarketSource · Medical Design & Outsourcing
WESTPAK adds vacuum decay CCIT testing service
WESTPAK, a contract testing lab serving pharmaceutical and medical device makers for over 40 years, has added Vacuum Decay CCIT (Container Closure Integrity Testing) to its service portfolio. The non-destructive leak detection method provides faster audit-ready results as regulatory requirements tighten. The service supports manufacturers validating sealed containers and closures for drug and device products.
- 061MarketSource · Medical Device Network
Novanta outlays $1.45bn for Riverpoint Medical buyout
Novanta announced the acquisition of Riverpoint Medical for $1.45 billion. The deal expands Novanta's footprint into minimally invasive surgery and strengthens its medical consumables portfolio, representing a significant strategic move to broaden its surgical and procedural device offerings.
- 062MarketSource · Medical Device Network
Sophia Genetics and MSK join forces to develop precision oncology hub
Sophia Genetics and Memorial Sloan Kettering Cancer Center have partnered to develop a precision oncology hub focused on multimodal approaches. The collaboration aims to advance diagnostic and treatment strategies in oncology through combined expertise in genetic analysis and clinical care.
- 063MarketSource · Medical Design & Outsourcing
Cordica Medical acquires RapidWerks micro-molding capability
Cordica Medical, a medical device contract development and manufacturing organization, has acquired RapidWerks' micro-molding capabilities. The acquisition expands Cordica's precision manufacturing capacity for miniaturized medical devices, adding dedicated automated micro-molding for mass production to its integrated design and manufacturing services.
- 064MarketSource · MedCity News
CereVasc Rakes In $85M to Challenge Traditional Brain Shunt Surgery
CereVasc closed an $85 million Series C funding round to support development of its eShunt system, a minimally invasive alternative to conventional brain shunt surgery for hydrocephalus treatment. The company expects to complete a pivotal clinical trial and submit to the FDA in 2027.
- 065MarketSource · Medical Device Network
CereVasc raises $85m to advance hydrocephalus treatment
CereVasc raised $85 million to advance development of eShunt, an implantable system for treating normal pressure hydrocephalus through cerebrospinal fluid drainage. The funding supports clinical advancement and commercialization of the device.
- 066MarketSource · Medical Device Network
ResMed completes $340m Noctrix Health acquisition
ResMed completed its acquisition of Noctrix Health for $340 million. Noctrix's lead product, Nidra, is a neuromodulation device targeting peroneal nerves to treat restless leg syndrome symptoms. The deal expands ResMed's portfolio in sleep and respiratory care.
- 067MarketSource · MedCity News
Novellia Snags $18M for Its Real-World Data Platform
Novellia raised $18 million in Series A funding to expand its real-world data platform, which enables patients to consolidate medical records and share anonymized data with pharmaceutical companies. The platform aims to improve drug research by sourcing more complete healthcare datasets directly from patient sources.
- 068MarketSource · Mobi Health News
Elation Health acquires Aster to expand AI-enabled EHR capabilities
Elation Health acquired Aster, an EHR startup focused on women's health, to expand its AI-enabled electronic health record capabilities. Elation, a California-based supplier of cloud-based clinical EHRs, telehealth services, and practice management software for primary care providers, added Aster's women's health specialization to its existing portfolio of digital tools for healthcare providers.
- 069MarketSource · Medical Device Network
Subtle Medical raises $33m, appoints new CEO to advance AI image software
Subtle Medical closed a $33 million Series C funding round and appointed industry veteran Ohad Arazi as CEO to lead global commercialization of its AI imaging software. The company develops artificial-intelligence tools for medical image processing and analysis.
- 070MarketSource · Medical Device Network
Veritas Aortic Solutions raises $12m for aortic disease treatment advance
Veritas Aortic Solutions secured $12 million in funding to advance its technology for treating acute aortic root and ascending aorta pathologies without open heart surgery. The company is developing a minimally invasive approach to address aortic disease, positioning itself as an alternative to conventional surgical intervention.
- 071MarketSource · Medical Device Network
Countable Labs raises $26m for PCR technology advancement
Countable Labs closed a $26 million funding round to advance its PCR technology platform, which the company claims delivers at least tenfold sensitivity improvement over conventional PCR. The capital will support product development and commercialization of the diagnostic tool.
- 072MarketSource · Healthcare IT News
Telehealth roundup: Amazon hires Amwell founder, Teladoc expands access and more
Amazon appointed Dr. Roy Schoenberg, founder of Amwell, as senior vice president of its Health Services division. Separately, Walmart integrated Teladoc Health services into its Better Care Services platform to expand customer access to third-party providers. GoodRx launched a new subscription service for generic medications.
- 073MarketSource · Healthcare IT News
AstraZeneca, Roche to boost digital pathology uptake in APAC and more briefs
AstraZeneca and Roche Diagnostics Asia Pacific signed a three-year memorandum of understanding to promote AI-powered digital pathology and biomarker testing for breast and lung cancer across nine Asian markets. The partnership aims to expand adoption of digital pathology solutions in the region.
- 074MarketSource · MedCity News
Walmart, Teladoc Team Up to Expand Access to Virtual Care
Walmart and Teladoc Health announced a partnership integrating Teladoc's virtual care services into Walmart's Better Care Services platform, expanding access to remote clinical consultations through the retail giant's existing consumer base and healthcare infrastructure.
- 075MarketSource · Mobi Health News
Signos raises $20M for glucose monitoring system for weight management
Signos, which makes an over-the-counter glucose monitoring system marketed for weight management, raised $20 million in funding from Dexcom, Google Ventures, and Blue Cross Blue Shield of Alabama. The funding round includes a partnership with Dexcom that will make Signos available through Dexcom's direct-to-consumer continuous glucose monitoring website.
- 076MarketSource · MedCity News
Oura Files for IPO As Healthcare Ambitions Grow
Oura, maker of smart rings for health monitoring, has filed for an initial public offering as it expands beyond sleep tracking into broader healthcare applications. The move signals the company's shift from consumer wellness toward clinical-grade monitoring and reflects growing investor appetite for wearable health-tech vendors.
- 077MarketSource · Mobi Health News
Swoop acquires Nimble expanding pharmacy connectivity services
Healthcare engagement platform Swoop has acquired prescription management platform Nimble to expand its pharmacy connectivity and medication fulfillment capabilities. The acquisition adds pharmacy integration services to Swoop's omnichannel marketing and engagement platform for life sciences vendors and healthcare providers.
- 078MarketSource · Medical Device Network
Olympus agrees $270m BioProtect buyout to expand prostate cancer offerings
Olympus has agreed to acquire BioProtect for $270 million to expand its prostate cancer treatment portfolio. BioProtect's primary product is a tissue-protection spacer system used during radiation therapy for prostate cancer. The acquisition strengthens Olympus's specialty medical and oncology device offerings.
- 079MarketSource · Medical Device Network
Align Technology to establish $200m manufacturing facility in India
Align Technology announced a $200 million investment to build a new manufacturing facility in Hyderabad, India, scheduled to open in 2027. The expansion marks the company's strategy to diversify production capacity and strengthen its supply chain in the Asia-Pacific region.
- 080MarketSource · Healthcare IT News
Innovaccer acquires CaduceusHealth with an eye toward autonomous RCM
Innovaccer acquired CaduceusHealth for $66 million to expand its revenue cycle management platform with enhanced capabilities for addressing claim denials. The deal adds agentic AI functionality to Innovaccer's RCM offerings, targeting a key pain point for healthcare providers managing high denial rates.